Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA).

A. Lopes (Lisboa, Portugal), N. Cortesão (Porto, Portugal), I. Pinto (Lisboa, Portugal), M. Dias (Porto, Portugal), I. Teixeira (Porto, Portugal)

Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Session: Pathophysiology and treatment of obstructive sleep apnoea
Session type: E-poster session
Number: 1341
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Lopes (Lisboa, Portugal), N. Cortesão (Porto, Portugal), I. Pinto (Lisboa, Portugal), M. Dias (Porto, Portugal), I. Teixeira (Porto, Portugal). Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA).. 1341

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
Source: Sleep and Breathing Conference 2021
Year: 2021

Catecholamines and obstructive sleep apnea (OSA) severity: response to positive airway pressure (PAP) therapy
Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea
Year: 2009


Association between obstructive sleep apnea (OSA) and depression and the effect of continuous positive airway pressure (CPAP) treatment
Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology
Year: 2012


Prediction of effective continuous positive airway pressure (CPAP) in obstructive sleep apnea syndrome (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 111s
Year: 2005

Prevalence and determinants of residual excessive daytime sleepiness (RES) in patients treated with continuous positive airway pressure (CPAP) for obstructive sleep apnea (OSA).
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020


Outcomes in patients with REM-related obstructive sleep apnoea (REM-OSA) treated with continuous positive airway pressure (CPAP)
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019


Prevalence and causes of residual sleepiness (RS) 12 months after continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea syndome (OSAS)
Source: Annual Congress 2010 - Sleep disorders: neurology, smoking and daytime sleepiness
Year: 2010

Effects of continuous positive airway pressure (CPAP) on quality of life in patients with obstructive sleep apnea syndromes (OSAS)
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010

Impact of humidification on compliance and side effects in obstructive sleep apnea (OSA) patients under auto continuous positive airway pressure (ACPAP) therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 409s
Year: 2006

Disease characteristics and adherence to treatment with continous positive airway pressure in men and women severe obstructive sleep apnea (OSA).
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019

Angiogenic factors in obstructive sleep apnea syndrome (OSA). Effects of nasal continuous positive airway pressure treatment (CPAP)
Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea
Year: 2010


Effect of continuous positive airway pressure treatment (CPAP) in angiogenic growth factors‘ expression in patients with COPD and obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010

Positional obstructive sleep apnea (OSA) and automatic positive airway pressure (APAP) therapy
Source: Annual Congress 2012 - Technology, screening and questionnaires in OSA
Year: 2012


Recent weight history in patients with obstructive sleep apnea syndrome (OSAS) prior to continuous positive airway pressure (CPAP) therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 648s
Year: 2006

Influence of nasal obstruction (NO) on obstructive sleep apnea (OSA) severity and continuous positive airway pressure (CPAP) adaptation problems
Source: Annual Congress 2010 - The upper airway and oral appliances
Year: 2010

Does positional apnea influence optimum continuous positive airway pressure (CPAP) in obstructive sleep apnea (OSA)?
Source: Eur Respir J 2005; 26: Suppl. 49, 111s
Year: 2005

Effect of continuous positive airway pressure (CPAP) treatment on proangiogenic factors of angiogenesis in obstructive sleep apnea (OSA) patients
Source: Eur Respir J 2005; 26: Suppl. 49, 39s
Year: 2005

Natural history of idiopathic pulmonary fibrosis (IPF) associated with obstructive sleep apnea (OSA) with or without continuous positive airway pressure (CPAP)
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018


Effect of automatic positive airway pressure (APAP) therapy on blood pressure (BP) in patients with obstructive sleep apnea (OSA) and hypertension
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008


Pharyngeal compliance (Cph) in patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2006; 28: Suppl. 50, 641s
Year: 2006